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Gastrointestinal involvement is frequent in patients with systemic lupus erythematosus (SLE). Eosinophilic gastroenteritis,
however, has only rarely been described in rheumatological conditions, despite its reported connection to autoimmune diseases,
suchashypereosinophilicsyndrome,vasculitides,andsystemicmastoidosis.Itpresentstypicallywithabdominalpainanddiarrhea
and is only exceptionally associated with ascites. Diagnosis can be problematic, as several other clinical conditions (malignancies,
infection/tuberculosis, and inﬂammatory bowel diseases) have to be ruled out. It is basically a nonsurgical disease, with excellent
recovery on conservative treatment. We report the rare case of a young woman with overlap syndrome who presented with
abdominalpainandascites.Thediagnosisofeosinophilicenteritiswasmadebasedonclinical,radiological,andlaboratorycriteria.
The patient was treated with corticosteroids with excellent response.
Copyright © 2009 Spyros Aslanidis et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1.Introduction
Gastrointestinal involvement is frequent in patients with sys-
temic lupus erythematosus (SLE). In a series of 201 patients
with childhood-onset SLE the most frequent symptom was
abdominal pain. It was mostly related to lupus involvement,
especially ascites, and pancreatitis, more rarely to treatment-
induced events or infection and never to events unrelated
to SLE [1]. Eosinophilic gastroenteritis has only rarely been
describedinrheumatologicalconditions,suchasrheumatoid
arthritis and systemic lupus erythematosus [2–6], despite
its reported connection to autoimmune diseases, such
as hypereosinophilic syndrome, vasculitides, and systemic
mastoidosis. It presents typically with abdominal pain and
diarrhea and is only exceptionally associated with ascites.
Diagnosis can be diﬃcult, as several other clinical con-
ditions (malignancies, infection/tuberculosis, and inﬂam-
matory bowel diseases) have to be ruled out. Diﬀerential
diagnosis from lupus enteritis (gastrointestinal vasculitis),
a common cause of acute abdominal pain associated with
small bowel wall thickening and ascites, involves exclusion
of mesenteric ischemia [7].
We report the rare case of a young woman with overlap
syndrome who presented with abdominal pain and ascites.
Based on clinical, radiological, and laboratory criteria, the
diagnosis of eosinophilic enteritis was made. The patient
was treated conservatively with corticosteroids with excellent
response.
2. Case Presentation
A 24-year-old woman presented with abdominal pain and
vomiting. She was previously well till 24 hours earlier when
shedevelopeddiﬀuseabdominalpain,nausea,andvomiting,
with gradual worsening. On clinical examination, the patient
was afebrile, tachycardic (108/min), with diﬀuse tenderness,
guarding of the entire abdomen and abdominal distension;
there were no active bowel sounds.
The patient’s medical history included heterozygous β-
thalassemia and a 6-year history of connective tissue disease
with overlapping features of systemic lupus erythemato-
sus and limited scleroderma, with positive antinuclear-
ANA, antiribonucleoprotein-anti-RNP, anti-DNA and anti-
β2-glycoprotein antibodies for which she was currently on2 Case Reports in Medicine
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Figure 1: Computed tomography scan of the abdomen performed.
(a) On day 3 of the patient’s admission, 4 days after initiation
of symptoms. Arrows: thickening/dilatation of the intestinal wall,
stars: ascitic ﬂuid. (b) Four days after initiation of treatment, with
marked improvement of the intestinal morphology, and moderate
reduction of the amount of ascitic ﬂuid.
methotrexate (10mg/week), hydroxychloroquine (400mg/
day) and low dose aspirin. Two months prior to this episode
she reported similar symptomatology, which responded well
to “classical” treatment (ranitidine and metoclopramide).
On the 3rd day after admission her ﬁndings persisted;
computed tomography (CT) scanning of the abdomen
revealed dilatation and marked contrast-enhanced thicken-
ing of the small intestinal wall, mainly ileum; other parts of
the small intestine (jejunum) and the large intestine were
unaﬀected. A substantial amount of ascitic ﬂuid was also
present (Figure 1(a)). Large vessels were patent, with no
signs of occlusion, venous thrombosis, intestinal ischemia,
or intestinal obstruction; no pathological lymph nodes were
observed.
The patient was referred to our hospital for further
evaluation and treatment.
Diagnostic paracentesis of the ascitic ﬂuid showed low
SAAG (serum/ascites albumin gradient), elevated lactic
dehydrogenase (LDH), and presence of eosinophils (23% of
800WBC/μL,52%neutrophils,and15%lymphocytes)inthe
ascitic ﬂuid without peripheral eosinophilia; the number of
peripheral eosinophils rose to 13% (1100/μL) on the 4th day
of her hospitalization. The PPD (tuberculin, puriﬁed protein
derivative) skin test and the cultures of the ascitic ﬂuid were
negative.
The diagnosis of eosinophilic enteritis was made based
on clinical, laboratory, and radiological criteria. Endoscopy
was not undertaken because of (a) the patient’s severe
clinical condition (peritonism and marked intestinal dilata-
tion), (b) the diﬃculty in accessing the aﬀected area
(ileum), and (c) the strong propability of negative biop-
sies in this particular (subserosal) type of involvement
[8].
The patient was treated with IV prednisolone (1mg/kg
daily for 7 days and gradual tapering) and IV cefo-
taxime, with rapid resolution of her symptoms and con-
siderable clinical improvement. A subsequent scan, per-
formed 4 days after initiation of treatment showed sig-
niﬁcant normalization of the morphology of the intesti-
n a lw a l lw i t hm o d e r a t er e d u c t i o no ft h ea s c i t i cﬂ u i d
(Figure 1(b)). Five months later, the patient was in
excellent clinical condition under a maintenance dose of
methylprednisolone (2mg every other day), soon to be
discontinued.
3. Discussion
Eosinophilic gastroenteritis is a heterogeneous and uncom-
mon disease, aﬀecting children as well as adults, whose
pathogenesis and etiology are not well understood. The
diagnosis of eosinophilic gastroenteritis is based on a high
degree of suspicion and represents a challenge to the
physician, not only because of its rarity, but also because
of the variety of clinical manifestations. No deﬁnite criteria
exist; diagnosis is based on a combination of clinical,
radiological, and histological ﬁndings. Clinically, the pres-
ence of gastrointestinal symptoms, the lack of evidence
of parasitic or extraintestinal eosinophilic disease and the
exclusion of intestinal lymphoma, Crohn’s disease or other
tumors, nodular and irregular thickening of the folds usually
in the distal stomach and proximal small bowel on CT
[9, 10], and the histologically proven intense eosinophilic
inﬁltration in any of the diﬀerent layers of at least one site
of the gastrointestinal tract suﬃce for the diagnosis [11–13].
Eosinophilic gastroenteritis is basically a nonsurgical disease,
with excellent recovery on conservative treatment [14, 15].
Steroids are usually indicated as ﬁrst line therapy for patients
with nonallergic eosinophilic gastroenteritis and provide
prompt and eﬀective relief of symptoms within a few days to
weeks. Most experts recommend doses similar to those used
in inﬂammatory bowel disease (1-2mg/kg per day), tapered
over a period of 3-4 months to induce remission. Relapses
however are frequently noted during steroid tapering or
after discontinuation, necessitating repeated steroid therapy
[15]. Therefore, long-term follow-up is warranted, despite
initialrapidimprovement,sincethereisnoagreementonthe
duration of treatment.Case Reports in Medicine 3
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